Prognostic Factors and Management of Patients with Choanal Atresia

J Pediatr. 2019 Jan:204:234-239.e1. doi: 10.1016/j.jpeds.2018.08.074. Epub 2018 Oct 2.

Abstract

Objective: To analyze prognostic factors in the management of patients with choanal atresia.

Study design: This is a review of 114 patients operated on for choanal atresia in a tertiary care center between November 1986 and November 2016, including clinical characteristics, surgical management, and postoperative course with final nasal patency. The data were collected in a database that was updated over time.

Results: Among the 114 patients, 78 were female, 77 presented with unilateral choanal atresia, and 37 presented with bilateral unilateral choanal atresia, corresponding to 151 nasal fossae. Forty-seven patients had associated abnormalities (41.2%), including CHARGE, diagnosed in 20 children (17.5%). At the end of follow-up, 91 patients (79.8%) had normal choanal patency. The identified risk factors of surgical failure were age <6 months (P = .004), weight <5 kg (P = .007), and bilateral choanal atresia (P < .001). The type of atresia, presence of associated abnormalities, surgical approach, stenting, and use of mitomycin were not significantly linked with the surgical results.

Conclusions: This series highlights the importance of the timing of surgery, which is guided by the clinical ability of the infant to tolerate the procedure. Endoscopic approaches are widely performed, but a transpalatal approach, necessary in some cases of bilateral choanal atresia, does not alter the results. Unilateral choanal atresia surgery should be delayed after age 6 months and/or weight >5 kg when possible.

Keywords: bilateral; choanal atresia; endoscopic repair; nasal obstruction; transpalatal; unilateral.

MeSH terms

  • Adolescent
  • Alkylating Agents / therapeutic use
  • Child
  • Child, Preschool
  • Choanal Atresia / surgery*
  • Endoscopy / adverse effects
  • Endoscopy / methods
  • Female
  • Humans
  • Infant
  • Male
  • Mitomycin / therapeutic use
  • Otorhinolaryngologic Surgical Procedures / adverse effects
  • Otorhinolaryngologic Surgical Procedures / methods*
  • Prognosis
  • Risk Factors
  • Stents / adverse effects
  • Stents / statistics & numerical data
  • Treatment Outcome

Substances

  • Alkylating Agents
  • Mitomycin